Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.906,71
1,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Brainstorm Cell Therapeutics Inc (BCLI) Brainstorm Cell Therapeutics Inc (BCLI) Notizie

Brainstorm Cell Therapeutics Inc

BCLI
0,4007
0,0024 (0,60%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202412:30PRNUSBrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn®..
23/2/202412:00PRNUSBrainStorm Cell Therapeutics Submits Special Protocol..
13/2/202412:30PRNUSBrainStorm Cell Therapeutics to Present at European Life..
12/2/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/12/202323:04EDGAR2Form 8-K - Current report
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
22/11/202322:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/11/202312:03EDGAR2Form 8-K - Current report
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
09/11/202322:01EDGAR2Form 8-K - Current report
08/11/202323:28EDGAR2Form DEF 14A - Other definitive proxy statements
07/11/202319:57PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
03/11/202321:07EDGAR2Form 8-K - Current report
24/10/202313:30EDGAR2Form 8-K - Current report
27/9/202316:10APSBiotech Shares Halted Premarket As FDA Reviews Application
05/9/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:21EDGAR2Form 8-K - Current report
07/8/202312:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:05EDGAR2Form 8-K - Current report
19/7/202315:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 0,394 Min: 0,366 Max: 0,43
Chiusura: 0,3983

La tua Cronologia

NASDAQ
BCLI
Brainstorm Cell Therapeu...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network